Sclerosing Activity [MoA] - N0000020024
Pharmacologic Class Information
| Pharmacologic Code | N0000020024 |
| Pharmacologic Name | Sclerosing Activity |
| Pharmacologic Uses |
|
| Pharmacologic Concept | Mechanisms of Action - [MoA] |
| Pharmacologic Concept Description | This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept. |
NDC Products with Sclerosing Activity
The table contains 3 products whose active ingredient are classified under the same pharmacologic class Sclerosing Activity [MoA].
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
|---|---|---|---|---|---|---|---|
| 67850-140 | Asclera | Non-Proprietary Name: Polidocanol | Injection, Solution | Intravenous | Methapharm, Inc | ACTIVE | |
| 67850-141 | Asclera | Non-Proprietary Name: Polidocanol | Injection, Solution | Intravenous | Methapharm, Inc | ACTIVE | |
| 67871-479 | Ethamolin | Non-Proprietary Name: Ethanolamine Oleate | Injection, Solution | Intravenous | Qol Medical, Llc. | ACTIVE |